Literature DB >> 28564606

Genome-wide Analysis of STAT3-Mediated Transcription during Early Human Th17 Cell Differentiation.

Subhash K Tripathi1, Zhi Chen2, Antti Larjo3, Kartiek Kanduri4, Kari Nousiainen5, Tarmo Äijo5, Isis Ricaño-Ponce6, Barbara Hrdlickova6, Soile Tuomela2, Essi Laajala2, Verna Salo2, Vinod Kumar6, Cisca Wijmenga6, Harri Lähdesmäki7, Riitta Lahesmaa8.   

Abstract

The development of therapeutic strategies to combat immune-associated diseases requires the molecular mechanisms of human Th17 cell differentiation to be fully identified and understood. To investigate transcriptional control of Th17 cell differentiation, we used primary human CD4+ T cells in small interfering RNA (siRNA)-mediated gene silencing and chromatin immunoprecipitation followed by massive parallel sequencing (ChIP-seq) to identify both the early direct and indirect targets of STAT3. The integrated dataset presented in this study confirms that STAT3 is critical for transcriptional regulation of early human Th17 cell differentiation. Additionally, we found that a number of SNPs from loci associated with immune-mediated disorders were located at sites where STAT3 binds to induce Th17 cell specification. Importantly, introduction of such SNPs alters STAT3 binding in DNA affinity precipitation assays. Overall, our study provides important insights for modulating Th17-mediated pathogenic immune responses in humans.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  ChIP-seq; SNP; STAT3; Th17 cell differentiation; human

Mesh:

Substances:

Year:  2017        PMID: 28564606     DOI: 10.1016/j.celrep.2017.05.013

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  33 in total

Review 1.  The molecular details of cytokine signaling via the JAK/STAT pathway.

Authors:  Rhiannon Morris; Nadia J Kershaw; Jeffrey J Babon
Journal:  Protein Sci       Date:  2018-12       Impact factor: 6.725

Review 2.  Genome editing to define the function of risk loci and variants in rheumatic disease.

Authors:  Yuriy Baglaenko; Dana Macfarlane; Alexander Marson; Peter A Nigrovic; Soumya Raychaudhuri
Journal:  Nat Rev Rheumatol       Date:  2021-06-29       Impact factor: 20.543

3.  Aberrantly expressed Bruton's tyrosine kinase preferentially drives metastatic and stem cell-like phenotypes in neuroblastoma cells.

Authors:  Narpati Wesa Pikatan; Yen-Lin Liu; Oluwaseun Adebayo Bamodu; Michael Hsiao; Wen-Ming Hsu; Sofia Mubarika Haryana; Tsu-Yi Chao; Chi-Tai Yeh
Journal:  Cell Oncol (Dordr)       Date:  2020-07-23       Impact factor: 6.730

4.  JMJD3 Promotes Porphyromonas gingivalis Lipopolysaccharide-Induced Th17-Cell Differentiation by Modulating the STAT3-RORc Signaling Pathway.

Authors:  Doudou Huang; Chi Zhang; Panpan Wang; Xiting Li; Li Gao; Chuanjiang Zhao
Journal:  DNA Cell Biol       Date:  2022-07-22       Impact factor: 3.550

5.  Ezh2Y641F mutations co-operate with Stat3 to regulate MHC class I antigen processing and alter the tumor immune response in melanoma.

Authors:  Sarah M Zimmerman; Samantha J Nixon; Pei Yu Chen; Leela Raj; Sofia R Smith; Rachel L Paolini; Phyo Nay Lin; George P Souroullas
Journal:  Oncogene       Date:  2022-10-11       Impact factor: 8.756

6.  IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors.

Authors:  Sahil Gupta; Arpit Jain; Shahzad Nawaz Syed; Ryan G Snodgrass; Beatrice Pflüger-Müller; Matthias S Leisegang; Andreas Weigert; Ralf P Brandes; Ingo Ebersberger; Bernhard Brüne; Dmitry Namgaladze
Journal:  Oncoimmunology       Date:  2018-07-30       Impact factor: 8.110

7.  Transcription factor c-Maf is a checkpoint that programs macrophages in lung cancer.

Authors:  Min Liu; Zan Tong; Chuanlin Ding; Fengling Luo; Shouzhen Wu; Caijun Wu; Sabrin Albeituni; Liqing He; Xiaoling Hu; David Tieri; Eric C Rouchka; Michito Hamada; Satoru Takahashi; Andrew A Gibb; Goetz Kloecker; Huang-Ge Zhang; Michael Bousamra; Bradford G Hill; Xiang Zhang; Jun Yan
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

8.  miR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2.

Authors:  Enrique Fuentes-Mattei; Recep Bayraktar; Taghi Manshouri; Andreia M Silva; Cristina Ivan; Diana Gulei; Linda Fabris; Nayra Soares do Amaral; Pilar Mur; Cristina Perez; Elizabeth Torres-Claudio; Mihnea P Dragomir; Adriana Badillo-Perez; Erik Knutsen; Pranav Narayanan; Leonard Golfman; Masayoshi Shimizu; Xinna Zhang; Wanke Zhao; Wanting Tina Ho; Marcos Roberto Estecio; Geoffrey Bartholomeusz; Ciprian Tomuleasa; Ioana Berindan-Neagoe; Patrick A Zweidler-McKay; Zeev Estrov; Zhizhuang J Zhao; Srdan Verstovsek; George A Calin; Roxana S Redis
Journal:  JCI Insight       Date:  2020-01-16

9.  EGFR Activates a TAZ-Driven Oncogenic Program in Glioblastoma.

Authors:  Minling Gao; Yi Fu; Mingyao Ying; Weiqiang Zhou; Gege Gui; Bachuchu Lal; Yunqing Li; Shuli Xia; Hongkai Ji; Charles G Eberhart; John Laterra
Journal:  Cancer Res       Date:  2021-04-28       Impact factor: 12.701

10.  Systems analysis of human T helper17 cell differentiation uncovers distinct time-regulated transcriptional modules.

Authors:  Alessia Capone; Chiara Naro; Manuela Bianco; Marco De Bardi; Floriane Noël; Paolo Macchi; Luca Battistini; Vassili Soumelis; Elisabetta Volpe; Claudio Sette
Journal:  iScience       Date:  2021-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.